Article Text

Download PDFPDF
Rethinking presbyopia: results of bilateral refractive lens exchange with trifocal intraocular lenses in 17 603 patients
  1. Luis F Brenner1,
  2. Kristin Nistad2,
  3. Urban Schonbeck3
  1. 1Medical Director Norway, Memira Eye Center, Oslo, Norway
  2. 2Clinical Excellence and Development Manager, Memira Eye Center, Oslo, Norway
  3. 3Head Medical Director, Memira Eye Center, Stockholm, Sweden
  1. Correspondence to Dr Luis F Brenner, Memira AS, 0369 Oslo, Norway; luis.brenner{at}memira.no

Abstract

Purpose To evaluate the safety and effectiveness of bilateral refractive lens exchange (RLE) with trifocal intraocular lens (IOL) as the surgical treatment of presbyopia.

Settings Memira AS. Norway, Sweden and Denmark.

Design Multicentric retrospective interventional case series.

Methods 17 603 consecutive patients submitted to bilateral presbyopic RLE with trifocal IOLs from 2013 to 2019. The main outcomes were manifest refraction spherical equivalent (MRSE), uncorrected distance (UDVA) and near (UNVA) visual acuity, corrected distance visual acuity (CDVA), vision gain/loss, safety and efficacy indices, IOL power calculation accuracy and rate of excimer laser enhancements.

Results Three months postoperatively, the mean MRSE was 0.00±0.40 diopters (D), mean binocular UDVA was −0.03±0.09, with 14 470 patients (82.2%) with combined binocular UDVA and UNVA equal or better than 0.00 and Jaeger 3. Approximately 86% (n=30.124) of the eyes were within 0.50D of MRSE. Enhancement surgery was performed in 5810 eyes (16.5%). IOL power calculation refining improved accuracy and reduced enhancements rate from 20% in 2013 to 12% in 2019. Safety and efficacy indices were 0.98±0.11 and 0.85±0.18, respectively. Myopic eyes presented significant higher safety (1.00±0.19) and efficacy indices (0.87±0.19), with p<0.005. Approximately 0.38% (n=130) of the eyes lost two or more lines of CDVA, with cystoid macular oedema (n=53, 40.8%) and posterior capsular opacification (n=35, 26.9%) as the main causes. After proper care, the final incidence of two or more lines of vision loss was 0.08% (28 eyes).

Conclusions Presbyopic RLE with trifocal IOL is a safe and effective modality of treatment for patients with presbyopia.

  • treatment surgery
  • lens and zonules

Data availability statement

No data are available. Not applicable.

Statistics from Altmetric.com

Data availability statement

No data are available. Not applicable.

View Full Text

Footnotes

  • Presented at This manuscript was presented as a free paper at the ESCRS virtual meeting in Amsterdam, Netherlands, October 2020.

  • Contributors All authors have contributed to the manuscript: LFB: Guarantor. Substantial contributions to the conception or design of the work. Analysis and interpretation of data for the work. Drafting the work. Final approval of the version to be published. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. KN: Substantial contributions to the conception or design of the work. Database acquisition and interpretation of data for the work. Revising the work critically for important intellectual content. Final approval of the version to be published. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. US: Substantial contributions to the conception or design of the work. Revising the work critically for important intellectual content. Final approval of the version to be published. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.